Blockade of cholecystokinin-2 receptor and cyclooxygenase-2 synergistically induces cell apoptosis, and inhibits the proliferation of human gastric cancer cells in vitro

Cancer Letters

Volumn 263, Issue 2, 2008, Pages 302-311

  Sun, Wei Hao ^a   Zhu, Feng ^b   Chen, Guo Sheng ^a   Su, Han ^c   Luo, Cheng ^d,e   Zhao, Qin Shi ^d   Zhang, Yuan ^a   Shao, Yun ^a   Sun, Jian ^f   Zhou, Su Ming ^a   Ding, Guo Xian ^a   Cheng, Yun Lin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c General Office of Jiangsu Provincial Government   (China)

^d KUNMING INSTITUTE OF BOTANY   (China)

^e UNIVERSITY OF TURKU   (Finland)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Cholecystokinin 2 receptor; Cyclooxygenase 2; MKN 45 cell; Proliferation

Indexed keywords

AG 041R; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CYCLOOXYGENASE 2; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENTIATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; RECEPTOR BLOCKING; STOMACH CANCER; UPREGULATION;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2 INHIBITORS; GASTRINS; HUMANS; RECEPTOR, CHOLECYSTOKININ B; STOMACH NEOPLASMS;

EID: 41649085978     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.01.012     Document Type: Article

References (40)

1. Varro A., Noble P.J., Wroblewski L.E., Bishop L., and Dockray G.J. Gastrin-cholecystokinin(B) receptor expression in AGS cells is associated with direct inhibition and indirect stimulation of cell proliferation via paracrine activation of the epidermal growth factor receptor. Gut 50 (2002) 827-833
2. Lee H.K., Lee H.J., Hur K., Lee H.S., Kim W.H., Michaeli D., Choe K.J., and Yang H.K. Growth effect of gastrin on gastric cancer and its clinical implications for gastric cancer surgery. Oncol. Rep. 14 (2005) 383-388
3. Song D.H., Rana B., Wolfe J.R., Crimmins G., Choi C., Albanese C., Wang T.C., Pestell R.G., and Wolfe M.M. Gastrin-induced gastric adenocarcinoma growth is mediated through cyclin D1. Am. J. Physiol. Gastrointest. Liver Physiol. 285 (2003) G217-G222
4. McWilliams D.F., Watson S.A., Crosbee D.M., Michaeli D., and Seth R. Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines. Gut 42 (1998) 795-798
5. Hellmich M.R., Rui X.L., Hellmich H.L., Fleming R.Y., Evers B.M., and Townsend C.M. Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth. J. Biol. Chem. 275 (2000) 32122-32128
6. Schally A.V., Szepeshazi K., Nagy A., Comaru-Schally A.M., and Halmos G. New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs. Cell. Mol. Life Sci. 61 (2004) 1042-1068
7. van Rees B.P., Saukkonen K., Ristimäki A., Polkowski W., Tytgat G.N., Drillenburg P., and Offerhaus G.J. Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J. Pathol. 196 (2002) 171-179
8. Sun W.H., Sun Y.L., Fang R.N., Shao Y., Xu H.C., Xue Q.P., Ding G.X., and Cheng Y.L. Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis. Jpn. J. Clin. Oncol. 35 (2005) 707-713
9. Sawaoka H., Tsuji S., Tsujii M., Gunawan E.S., Sasaki Y., Kawano S., and Hori M. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab. Invest. 79 (1999) 1469-1477
10. Konturek P.C., Hartwich A., Zuchowicz M., Labza H., Pierzchalski P., Karczewska E., Bielanski W., Hahn E.G., and Konturek S.J. Helicobacter pylori, gastrin and cyclooxygenases in gastric cancer. J. Physiol. Pharmacol. 51 (2000) 737-749
11. Watson S.A., Morris T.M., McWilliams D.F., Harris J., Evans S., Smith A., and Clarke P.A. Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence. Br. J. Cancer 87 (2002) 567-573
12. Konturek P.C., Kania J., Kukharsky V., Ocker S., Hahn E.G., and Konturek S.J. Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor and apoptosis-related proteins in gastric epithelial cells. J. Physiol. Pharmacol. 54 (2003) 17-32
13. Yao M., Song D.H., Rana B., and Wolfe M.M. COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer. Br. J. Cancer 87 (2002) 574-579
14. Watson S.A., Crosbee D.M., Morris D.L., Robertson J.F., Makovec F., Rovati L.C., and Hardcastle J.D. Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth. Br. J. Cancer 65 (1992) 879-883
15. Tsuji S., Kawano S., Sawaoka H., Takei Y., Kobayashi I., Nagano K., Fusamoto H., and Kamada T. Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostaglandins Leukot. Essent. Fatty Acids 55 (1996) 179-183
16. Chou T.C., and Talalay P. Quantitative analysis of dose-effect relationship: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22 (1984) 27-55
17. Shen H., Sun W.H., Xue Q.P., Wu J., Cheng Y.L., Ding G.X., Fu H.Y., Tsuji S., and Kawano S. Influences of Helicobacter pylori on cyclooxygenase-2 expression and prostaglandinE2 synthesis in rat gastric epithelial cells in vitro. J. Gastroenterol. Hepatol. 21 (2006) 754-758
18. Stewart J.J.P. Optimization of parameters for semiempirical methods. I. Method. J. Comput. Chem. 10 (1989) 209-220
19. Stewart J.J.P. Optimization of parameters for semiempirical methods. II. Applications. J. Comput. Chem. 10 (1989) 221-264
20. Stewart J.J. MOPAC: a semiempirical molecular orbital program. J. Comput. Aided Mol. Des. 4 (1990) 1-105
21. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., and Olson A.J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19 (1998) 1639-1662
22. Huey R., Morris G.M., Olson A.J., and Goodsell D.S. A semiempirical free energy force field with charge-based desolvation. J. Comput. Chem. 28 (2007) 1145-1152
23. Williams G.T., and Smith C.A. Molecular regulation of apoptosis: genetic controls on cell death. Cell 74 (1993) 777-779
24. Adams J.M., and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281 (1998) 1322-1326
25. Burlacu A. Regulation of apoptosis by Bcl-2 family proteins. J. Cell. Mol. Med. 7 (2003) 249-257
26. Watson S., Durrant L., and Morris D. Gastrin: growth enhancing effects on human gastric and colonic tumour cells. Br. J. Cancer 59 (1989) 554-558
27. Hur K., Kwak M.K., Lee H.J., Park D.J., Lee H.K., Lee H.S., Kim W.H., Michaeli D., and Yang H.K. Expression of gastrin and its receptor in human gastric cancer tissues. J. Cancer Res. Clin. Oncol. 132 (2006) 85-91
28. Van Solinge W.W., and Rehfeld J.F. Co-transcription of the gastrin and cholecystokinin genes with selective translation of gastrin mRNA in a human gastric carcinoma cell line. FEBS Lett. 309 (1992) 47-50
29. Ishizuka J., Martinez J., Townsend C.M., and Thompson J.C. The effect of gastrin on growth of human stomach cancer cells. Ann. Surg. 215 (1992) 528-534
30. Piontek M.K., and Hengels K.J. Differential mode of action of high- and low-affinity CCK/gastrin receptor antagonists in growth inhibition of gastrin-responsive human gastric adenocarcinoma cells in vitro. Anticancer Res. 13 (1993) 715-720
31. Konturek P.C., Konturek S.J., Sulekova Z., Meixner H., Bielanski W., Starzynska T., Karczewska E., Marlicz K., Stachura J., and Hahn E.G. Expression of hepatocyte growth factor, transforming growth factor alpha, apoptosis related proteins Bax and Bcl-2, and gastrin in human gastric cancer. Aliment. Pharmacol. Ther. 15 (2001) 989-999
32. Konturek P.C., Konturek S.J., Bielanski W., Karczewska E., Pierzchalski P., Duda A., Starzynska T., Marlicz K., Popiela T., Hartwich A., and Hahn E.G. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans. J. Physiol. Pharmacol. 50 (1999) 857-873
33. Tsujii M., and DuBois R.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpression prostaglandin endoperoxide synthase-2. Cell 83 (1995) 493-501
34. Honjo S., Kase S., Osaki M., Ardyanto T.D., Kaibara N., and Ito H. COX-2 correlates with F-box protein, Skp2 expression and prognosis in human gastric carcinoma. Int. J. Oncol. 26 (2005) 353-360
35. Yip-Schneider M.T., Sweeny C.J., Jung S.H., Crowell P.L., and Marshall M.S. Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells. J. Pharmacol. Exp. Ther. 298 (2001) 976-985
36. Komori M., Tsuji S., Sun W.H., Tsujii M., Kawai N., Yasumaru M., Kakiuchi Y., Kimura A., Sasaki Y., Higashiyama S., Kawano S., and Hori M. Gastrin enhances gastric mucosal integrity through cyclooxygenase-2 up-regulation in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 283 (2002) G1368-G1378
37. Tsuji S., Sun W.H., Tsujii M., Kawai N., Kimura A., Kakiuchi Y., Yasumaru S., Komori M., Murata H., Sasaki Y., Kawano S., and Hori M. Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats. J. Pharmacol. Exp. Ther. 303 (2002) 1301-1308
38. Konturek P.C., Konturek S.J., Pierzchalski P., Starzyńska T., Marlicz K., Hartwich A., Zuchowicz M., Darasz Z., Papiez D., and Hahn E.G. Gastric MALT-lymphoma gastrin, and cyclooxygenases. Acta Gastroenterol. Belg. 65 (2002) 17-23
39. Roberts E.G., Vona-Davis L., Riggs D.R., Jackson B.J., Hohseni H., Kandzari S.J., and McFadden D.W. COX-2 inhibition and cancer: experimental findings and clinical correlates. W. V. Med. J. 100 (2004) 96-101
40. Krum H., Liew D., Aw J., and Haas S. Cardiovascular effects of selective cyclooxygenase-2 inhibitors. Expert Rev. Cardiovasc. Ther. 2 (2004) 265-270